Allspring Global Investments
PRAX icon

Allspring Global Investments’s Praxis Precision Medicines PRAX Stock Holding History

Allspring Global Investments’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Sell
6,884
-1,652
-19% -$523K ﹤0.01% 1051
2026
Q1 		$2.73M Buy
8,536
+6,804
+393% +$2.1M ﹤0.01% 997
2025
Q4 		$496K Buy
+1,732
New +$323K ﹤0.01% 1381
2023
Q2 		– Sell
-1,078
Closed -$13.1K – 2802
2023
Q1 		$13.1K Hold
1,078
– – ﹤0.01% 2566
2022
Q4 		$38.5K Buy
+1,078
New +$33.6K ﹤0.01% 2415

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Allspring Global Investments's PRAX Position: Q2 2026 in Review

Allspring Global Investments reduced its Praxis Precision Medicines (PRAX) stake by 19% in Q2 2026, selling an estimated $523K and leaving 6,884 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Allspring Global Investments first reported a position in PRAX in Q4 2022 and has held it in 5 quarters since. The position peaked at $2.73M in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Allspring Global Investments held 6,884 shares of Praxis Precision Medicines worth $2.2M as of Q2 2026.
  • Allspring Global Investments sold 1,652 Praxis Precision Medicines shares in Q2 2026, an estimated $523K.
  • Praxis Precision Medicines made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1051 holding.
  • Allspring Global Investments first reported a position in Praxis Precision Medicines in Q4 2022 and has held it in 5 quarters since.
  • Allspring Global Investments's Praxis Precision Medicines position peaked at $2.73M in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.